HCWB ▼ -2.0% - HCW Biologics Inc. $HCWB - HCW Biologics Entered an Exclusive Distribution Agreement with Akron Biotech to Commercialize HCW11-006 as Reagent Used to Support Production of Highly Functional Human CAR-T Cells HCW Biologics shares fell 2.0% today despite announcing an exclusive distribution agreement with Akron Biotech to commercialize HCW11-006, a reagent designed to enhance human CAR-T cell production. The decline suggests investors may have been disappointed by the scope of the deal or anticipated a broader commercialization announcement. 08-SEP-2026 08:50 AM ET